ADIPOQ and endothelial dysfunction: However, regarding changes in plasma concentration of selected biomarkers of endothelial dysfunction, the predominant feature of S961-treated mice was a fall in plasma concentration of adiponectin, an adipokine known to exert anti-inflammatory, anti-atherosclerotic properties [48] by multiple mechanisms [39,49].